Skip to main content

Carbamazepine

NDC 70518-3699 · REMEDYREPACK INC.

Generic nameCarbamazepine
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength200 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryANDA

Packages

70518-3699-0 — 100 POUCH in 1 BOX (70518-3699-0) / 1 TABLET, EXTENDED RELEASE in 1 POUCH (70518-3699-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68788-7210 — CARBAMAZEPINE, 68788-7825 — Carbamazepine, 68999-802 — Carbamazepine, 68999-867 — Carbamazepine, 69452-312 — CARBAMAZEPINE, 70518-1433 — Carbamazepine, 70518-2242 — Carbamazepine, 70518-2426 — Carbamazepine, 70518-2841 — Carbamazepine, 70518-3146 — CARBAMAZEPINE, 70518-3773 — Carbamazepine, 70518-3911 — Carbamazepine, 70518-4167 — CARBAMAZEPINE, 70518-4492 — Carbamazepine, 70518-4682 — Carbamazepine, 70771-1468 — carbamazepine, 70771-1469 — carbamazepine, 70771-1470 — carbamazepine, 70954-240 — Carbamazepine, 71205-025 — CARBAMAZEPINE, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.